BioCentury | Mar 18, 2020
Politics, Policy & Law

Bay Area labs pare down to essentials following shelter-in-place directives

...trials, and how to understand the operational constraints of partnering organizations like CROs,” she said. TwoXAR Inc....
...San Diego-based Crown Bioscience Inc., has not experienced interruption of experiments. He said some of twoXAR’s...
...on countermeasures, is free to all who visit the site. Karen Tkach Tuzman, Associate Editor Stanford University Genentech Inc. twoXAR Inc. Canaan COVID19 COVID-19 shelter-in-place...
BioCentury | Mar 4, 2020
Management Tracks

Karp, Ghosh depart Biogen; plus Exelixis, Senti, Applied Therapeutics, Oncopeptides, Acacia and more

...Rubino was chief business and strategy officer at Omega Therapeutics. Artificial intelligence drug discovery company twoXAR Inc....
...head at Merck & Co. Inc. (NYSE:MRK) from March 2007 to December 2018. BioCentury Staff Applied Therapeutics Inc. twoXAR Inc. Rafael...
BioCentury | Feb 26, 2020
Product Development

Feb. 25 Quick Takes: Vanda’s Phase III miss; plus Iovance; 1st-twoXAR; app for AFib, stroke; ICER-Aetion; new-look Purple Book, and more

...cell therapies for cancer. 1st Biotherapeutics, twoXAR advance three AI compounds 1st Biotherapeutics Inc. and twoXAR Inc....
...and Paul Bonanos, Associate Editor tradipitant (ly686017, vly-686) Eylea, VEGF Trap-Eye, aflibercept ophthalmic solution Vanda Pharmaceuticals Inc. 1st Biotherapeutics Inc. twoXAR Inc. Harvard...
BioCentury | Sep 17, 2019
Company News

Management tracks: Gottlieb joins Aetion board; plus Alexion, Encoded, PhRMA, Rgenix, Lyra, twoXAR and Innoplexus

...SVP, clinical affairs. She was previously VP, clinical affairs at Avedro Inc.(NASDAQ:AVDR). Artificial intelligence biotech twoXAR Inc....
...engineering at IBM (NYSE:IBM). Jonathan Block, Associate Editor U.S. Food and Drug Administration (FDA) Aetion Inc. Rgenix Inc. Lyra Therapeutics Inc. twoXAR Inc. Pharmaceutical...
BioCentury | Jun 7, 2019
Emerging Company Profile

insitro: machine learning with designated data

...analyze affinity measurements and protein structures to predict the binding of small molecules to targets. twoXAR Inc....
...to build a mathematical disease model and predict the efficacy of compounds for a disease. twoXAR...
...Genentech Inc., South San Francisco, Calif. insitro Inc., Menlo Park, Calif. Stanford University, Stanford, Calif. twoXAR Inc....
BioCentury | Apr 18, 2019
Company News

Three steps forward, one step back for AI drug discovery

...partnerships for its Watson for Drug Discovery platform. In the newest deal, announced Thursday morning, twoXAR Inc....
...Seoul, South Korea), who will then optimize a lead candidate to take into IND-enabling studies. twoXAR...
...literature, genomics data and companies’ in-house databases. Mark Zipkin, Staff Writer Atomwise Inc. IBM Corp. IBM Watson SK Biopharmaceuticals Co. Ltd. twoXAR Inc....
BioCentury | Jan 11, 2019
Company News

1st Biotherapeutics, twoXAR to use AI to discover glioblastoma candidates

...Korea) and twoXAR Inc. (Mountain View, Calif.) partnered to discover and develop treatments for glioblastoma multiforme. twoXAR...
...disclosed. 1st Biotherapeutics Inc., Seongnam, South Korea twoXAR Inc., Mountain View, Calif. Business: Cancer Chris Lieu 1st Biotherapeutics Inc. twoXAR Inc....
BioCentury | Sep 21, 2018
Finance

A bigger ‘biome

...microbiome play. Its other recent investments in healthcare include AI companies Verge Genomics Inc. and twoXAR Inc....
BioCentury | Mar 23, 2018
Financial News

AI company twoXAR raises $10M series A

...AI company twoXAR Inc. (Palo Alto, Calif.) raised $10 million on March 19 in an untranched series...
...JP Lee and Andreessen Horowitz's Vijay Pande joined the company's board. twoXAR Inc., Palo Alto, Calif. Chris Lieu twoXAR Inc....
BioCentury | Mar 19, 2018
Financial News

AI company twoXAR raises $10M series A

...AI company twoXAR Inc. (Palo Alto, Calif.) raised $10 million in an untranched series A round led...
...the Stanford-StartX Fund. SoftBank's JP Lee and Andreessen Horowitz's Vijay Pande joined the company's board. Chris Lieu twoXAR Inc....
Items per page:
1 - 10 of 25
BioCentury | Mar 18, 2020
Politics, Policy & Law

Bay Area labs pare down to essentials following shelter-in-place directives

...trials, and how to understand the operational constraints of partnering organizations like CROs,” she said. TwoXAR Inc....
...San Diego-based Crown Bioscience Inc., has not experienced interruption of experiments. He said some of twoXAR’s...
...on countermeasures, is free to all who visit the site. Karen Tkach Tuzman, Associate Editor Stanford University Genentech Inc. twoXAR Inc. Canaan COVID19 COVID-19 shelter-in-place...
BioCentury | Mar 4, 2020
Management Tracks

Karp, Ghosh depart Biogen; plus Exelixis, Senti, Applied Therapeutics, Oncopeptides, Acacia and more

...Rubino was chief business and strategy officer at Omega Therapeutics. Artificial intelligence drug discovery company twoXAR Inc....
...head at Merck & Co. Inc. (NYSE:MRK) from March 2007 to December 2018. BioCentury Staff Applied Therapeutics Inc. twoXAR Inc. Rafael...
BioCentury | Feb 26, 2020
Product Development

Feb. 25 Quick Takes: Vanda’s Phase III miss; plus Iovance; 1st-twoXAR; app for AFib, stroke; ICER-Aetion; new-look Purple Book, and more

...cell therapies for cancer. 1st Biotherapeutics, twoXAR advance three AI compounds 1st Biotherapeutics Inc. and twoXAR Inc....
...and Paul Bonanos, Associate Editor tradipitant (ly686017, vly-686) Eylea, VEGF Trap-Eye, aflibercept ophthalmic solution Vanda Pharmaceuticals Inc. 1st Biotherapeutics Inc. twoXAR Inc. Harvard...
BioCentury | Sep 17, 2019
Company News

Management tracks: Gottlieb joins Aetion board; plus Alexion, Encoded, PhRMA, Rgenix, Lyra, twoXAR and Innoplexus

...SVP, clinical affairs. She was previously VP, clinical affairs at Avedro Inc.(NASDAQ:AVDR). Artificial intelligence biotech twoXAR Inc....
...engineering at IBM (NYSE:IBM). Jonathan Block, Associate Editor U.S. Food and Drug Administration (FDA) Aetion Inc. Rgenix Inc. Lyra Therapeutics Inc. twoXAR Inc. Pharmaceutical...
BioCentury | Jun 7, 2019
Emerging Company Profile

insitro: machine learning with designated data

...analyze affinity measurements and protein structures to predict the binding of small molecules to targets. twoXAR Inc....
...to build a mathematical disease model and predict the efficacy of compounds for a disease. twoXAR...
...Genentech Inc., South San Francisco, Calif. insitro Inc., Menlo Park, Calif. Stanford University, Stanford, Calif. twoXAR Inc....
BioCentury | Apr 18, 2019
Company News

Three steps forward, one step back for AI drug discovery

...partnerships for its Watson for Drug Discovery platform. In the newest deal, announced Thursday morning, twoXAR Inc....
...Seoul, South Korea), who will then optimize a lead candidate to take into IND-enabling studies. twoXAR...
...literature, genomics data and companies’ in-house databases. Mark Zipkin, Staff Writer Atomwise Inc. IBM Corp. IBM Watson SK Biopharmaceuticals Co. Ltd. twoXAR Inc....
BioCentury | Jan 11, 2019
Company News

1st Biotherapeutics, twoXAR to use AI to discover glioblastoma candidates

...Korea) and twoXAR Inc. (Mountain View, Calif.) partnered to discover and develop treatments for glioblastoma multiforme. twoXAR...
...disclosed. 1st Biotherapeutics Inc., Seongnam, South Korea twoXAR Inc., Mountain View, Calif. Business: Cancer Chris Lieu 1st Biotherapeutics Inc. twoXAR Inc....
BioCentury | Sep 21, 2018
Finance

A bigger ‘biome

...microbiome play. Its other recent investments in healthcare include AI companies Verge Genomics Inc. and twoXAR Inc....
BioCentury | Mar 23, 2018
Financial News

AI company twoXAR raises $10M series A

...AI company twoXAR Inc. (Palo Alto, Calif.) raised $10 million on March 19 in an untranched series...
...JP Lee and Andreessen Horowitz's Vijay Pande joined the company's board. twoXAR Inc., Palo Alto, Calif. Chris Lieu twoXAR Inc....
BioCentury | Mar 19, 2018
Financial News

AI company twoXAR raises $10M series A

...AI company twoXAR Inc. (Palo Alto, Calif.) raised $10 million in an untranched series A round led...
...the Stanford-StartX Fund. SoftBank's JP Lee and Andreessen Horowitz's Vijay Pande joined the company's board. Chris Lieu twoXAR Inc....
Items per page:
1 - 10 of 25